BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 13, 2008
View Archived Issues
Daiichi Sankyo updates recent activity
Read More
AVI initiates next-generation drug eluting stent trial with Global Therapeutics
Read More
Novexel commences phase II for NXL-104/ceftazidime combination in UTIs
Read More
Quigley completes phase IIb study of QR-333 in diabetic peripheral neuropathy
Read More
Vical completes enrollment in phase II CMV vaccine trial
Read More
Phase IIa results with INCB-018424 in rheumatoid arthritis lead to phase IIb trials
Read More
Phase I data reported for autoimmune disorders candidate LX-2931
Read More
RAPID data show radiographic activity in nonresponders, sustained benefits in extension study
Read More
HIV protease inhibitor saquinavir kills ovarian cancer cells
Read More
ACH-702: new data on preclinical antibacterial activity, pharmacokinetics
Read More
Pfizer reports on sulopenem prodrug antibiotics
Read More
Seroquel approved in Europe for new indications in bipolar disorder
Read More
Sevikar approved in Germany for hypertension
Read More
Sanofi-aventis reports new post hoc results from ATHENA trial of Multaq in AF/AFL
Read More
Boehringer announces results from the PETRO-Ex study of Pradaxa for stroke in AF
Read More
Yissum and BioLineRx enter license agreement for antihormone BL-5040 in IBD
Read More
Swissmedic approves ceftobiprole for complicated skin and soft tissue infections
Read More
Nymox reports positive results in 59-week study of NX-1207 for BPS
Read More
Novel antiobesity agents disclosed in recent patents
Read More
Recent Novartis patent discloses novel antiinflammatory agents
Read More
New diagnostic agents imparted by Merck Eprova
Read More
Antyra and Novo Nordisk sign licensing agreement for IGF antagonists
Read More
Ensemble and Roche extend collaboration for diagnostic technology in cancer therapy
Read More